Buprenorphine Patch

Buprenorphine Patch
Product Description

Amarin has developed a patch intended to be AB rated to Butrans®, but with the comparative advantages of having half of the drug content and also a reduced size (having less residual drug after 7 days of use). As the patch delivers the same amount of drug, this makes it more efficient.

On the marketing perspective, the main advantage is that having a patch with different drug load makes it not substitutable at pharmacy level under the narcotic law of certain countries (such as Germany). Considering that the first generation of Buprenorphine patches doesn´t have any innovative differentiation, suppliers are competing on a commodity business.

As a consequence of that, our bioequivalent formulation (Bup 2.0) would offer the advantage of building a high value niche.

Read more Show less

Amarin Technologies SA

  • AR
  • 2019
    On CPHI since
  • 2
    Certificates
  • 25 - 49
    Employees
Company types
CMO/CDMO
Contract Service
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Pharmaceutical Company (generic finished products)
View company profile
Categories
more categories Show less
Specifications
  • Details
    The product developed by Amarin is generic formulation of Butrans®, from Purdue Pharma LP, Napp Pharmaceuticals Ltd. and Norspan® from Mundipharma, which are the Reference Listed Drugs.



    The indication is: for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.



    It is presented in the following doses: 5, 7.5, 10, 15, 20, 30 and 40 mcg/h.


  • Model
    Transdermal Patch
More specifications Fewer specifications
Sales Markets
Show more Show less

Amarin Technologies SA

  • AR
  • 2019
    On CPHI since
  • 2
    Certificates
  • 25 - 49
    Employees
Company types
CMO/CDMO
Contract Service
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Pharmaceutical Company (generic finished products)
View company profile

More Products from Amarin Technologies SA (2)

  • Fentanyl Patch

    Product Fentanyl Patch

    Fentanyl is a synthetic analgesic related to phenylpiperidines, which interacts predominately with the opioid μ-receptor. Fentanyl primary actions are analgesia and sedation. Minimum effective analgesic serum concentrations of fentanyl in opioid naive patients range from 0.2 to 1.2 ng/mL, and side effects ...
  • Methylphenidate Patch

    Product Methylphenidate Patch

    Amarin patch is 33% smaller ant it also has one third less of the drug content. As the patch delivers the same amount of drug, this makes it 149% more efficient in comparison to the originator.

     Additionally, there has been multiple customers complains on Dyatrana due to backing ...

Amarin Technologies SA resources (1)